Breast Cancer Tumor Care Patient Observation Programme
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Female
Post Menopausal, Arthralgia
Female
Post Menopausal, Arthralgia
Trial Information
Breast Cancer Tumor Care Patient Observation Programme
Inclusion Criteria:
- Postmenopausal women
- Already on upfront Arimidex Therapy (Start 1-4 weeks before)
- HR+
Exclusion Criteria:
- Premenopausal women
- Tamoxifen switch patients
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Progression of disease and tolerability in general
Outcome Time Frame:
Baseline, every 3 month
Safety Issue:
No
Principal Investigator
Dr. Melichart
Investigator Role:
Study Chair
Investigator Affiliation:
Hospital Rudolfstiftung
Authority:
Austria: Agency for Health and Food Safety
Study ID:
NIS-OAT-ARI-2007/1
NCT ID:
NCT00660244
Start Date:
February 2008
Completion Date:
December 2009
Related Keywords:
- Post Menopausal
- Arthralgia
- Arimidex
- Post menopausal
- arthralgia
- Arthralgia
- Breast Neoplasms
Name | Location |
|---|
